Baker McKenzie, Wachtell Guide Servier's $2B Cancer Biz Buy
France's Servier announced Monday that it will further bolster its cancer portfolio with the acquisition of Agios Pharmaceuticals' oncology unit, in an up to $2 billion deal steered by Baker McKenzie...To view the full article, register now.
Already a subscriber? Click here to view full article